Both in Biotechnology
Kalaris Therapeutics vs MiNK Therapeutics
Over the past year KLRS returned −57.9% and INKT returned −21.1%; their daily moves had a correlation of 0.04.
KLRS −57.9% INKT −21.1%Growth of $1, one year, split-adjusted
| Metric | KLRS | INKT |
|---|---|---|
| Price | $2.10 | $10.62 |
| Market cap | $50.0M | $54.2M |
| Today | +2.44% | −1.60% |
| 1 month | −21.1% | −9.3% |
| 6 months | −58.5% | −5.3% |
| Year to date | −75.1% | −4.8% |
| 1 year | −57.9% | −21.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $93.5M | $8.8M |
| Dividend yield | — | — |
| Volatility (60d) | 56.4% | 50.9% |
| Short % of float | 5.4% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).